Report: Bayer shipped AIDS-risky drug overseas in the 1980s

05/22/2003 | · Sun (Baltimore), The

The New York Times reports Bayer knowingly sold a blood-clotting drug in Asia and Latin America for hemophiliacs that may have been tainted with HIV, while selling a safer version of the medicine in the U.S. The medicine was made with plasma from donors who may have been HIV-positive, but no test had been developed when they began selling the drug. Still, the report contends, Bayer continued selling potentially dangerous versions overseas even once testing was available.

View Full Article in: · Sun (Baltimore), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA